Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Egner-Höbarth, S; Welkerling, H; Windhager, R.
Bisphosphonates in the therapy of fibrous dysplasia. Relevant data and practical aspects
Orthopade. 2007; 36(2): 126- 130.
Doi: 10.1007/s00132-007-1046-y
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
- Egner -Höbarth Sigrun
- Co-Autor*innen der Med Uni Graz
- Windhager Reinhard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Fibrous dysplasia covers a variety of rather different clinical pictures. Its therapy therefore has to be individually adapted. In addition to the orthopaedic surgeon, endocrinologists and craniofacial surgeons are also involved in the process. In the present contribution the role of modern bisphosphonates as a conservative treatment strategy is discussed with regard to the prevalent therapeutic possibilities. The literature as well as personal experience show them to be an especially valid option for the treatment of polyostotic fibrous dysplasia and the various syndromes.
- Find related publications in this database (using NLM MeSH Indexing)
- Bone Density - drug effects
- Bone Density Conservation Agents - adverse effects
- Diphosphonates - adverse effects
- Fibrous Dysplasia of Bone - diagnosis
- Humans - diagnosis
- Magnetic Resonance Imaging - diagnosis
- Tomography, X-Ray Computed - diagnosis
- Treatment Outcome - diagnosis